Syneos Health Archives · BioBuzz

Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients

<img width="300" height="196" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904-300x196.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=60x39&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=120x78&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=180x118&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=240x157&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904-300x196.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 11, 2022October 11, 2022 Published by : BioBuzz Media

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced an expanded partnership with Datavant, the leader in helping organizations securely connect health data. The increasing collaboration between the companies will further leverage the full suite of capabilities in Datavant Switchboard and Datavant’s large data ecosystem to accelerate the clinical development and commercialization of new therapies for patients.

Syneos Health Releases Annual Sustainability Report

<img width="300" height="196" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904-300x196.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=60x39&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=120x78&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=180x118&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904.jpg?size=240x157&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/syneos-health-rgb-r-scaled-e1664986415904-300x196.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 5, 2022October 5, 2022 Published by : BioBuzz Media

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report. The Report spotlights how the Company and its more than 29,000 employees have acted on their shared purpose to lead with a product development mindset and expand the Company’s Environmental, Social and Governance (ESG) impact. The Company continues to advance external and internal initiatives associated with achieving its Vision – Shortening the Distance from Lab to Life®.